Zai Lab’s Partner argenx Secures FDA Approval for Vygart Hytrulo Prefilled Syringe in gMG and CIDP
China-based Zai Lab Limited (NASDAQ: ZLAB, HKG: 9688) and its Dutch partner argenx SE (NASDAQ:...
Pierre Fabre and RedRidge Bio Partner on Biparatopic Antibody Development for Precision Oncology
France’s Pierre Fabre Laboratories has entered into a strategic partnership with Switzerland-based RedRidge Bio AG...
INTCO Medical and JD Healthcare Partner to Innovate ‘Internet + Healthcare’ Service Models
China-based INTCO Medical (SHE: 300677), a high-tech manufacturer of medical consumables and equipment, has entered...
KingstronBio’s Prostyle A Valve Gains NMPA Approval, Setting New Benchmark in Transcatheter Aortic Valve Replacement
KingstronBio, a Changshu-based structural heart disease device manufacturer, has obtained marketing approval from China’s National...
iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology
Wuhan-based iRegene Therapeutics, a pioneer in AI-powered, chemically induced cell therapies, has reportedly raised close...
Novo Nordisk Invests BRL 6.4 Billion in Brazilian Manufacturing Expansion for Obesity Drugs
Denmark-based Novo Nordisk A/S (NYSE: NVO) has announced a significant investment of BRL 6.4 billion...
Jemincare Group Announces NMPA Approval of Generic Clenil for Asthma Treatment
China-based Jiangxi Jemincare Group has announced that it has received marketing approval from the National...
Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a...
Bayer’s Vitrakvi Fully Approved by FDA for NTRK Fusion Solid Tumors
Germany-based Bayer (ETR: BAYN) announced that it has received full approval from the US Food...
Luye Pharma Launches Rotigotine Luye in UK for Parkinson’s and Restless Leg Syndrome
China-based Luye Pharma Group (HKG: 2186) announced the market launch of Rotigotine Luye in the...
Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization
Japan-based Astellas Pharma Inc. (TYO: 4503) announced a strategic partnership with Shanghai Pharmaceuticals (SPH; SHA:...
CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine
China-based CK Life Sciences (HKG: 0775) has announced positive early results from preclinical studies of...
Kangtai Biological’s Pentavalent Rotavirus Vaccine Enters Phase III Trials
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) announced the enrollment of the first patient...
Zelgen Biopharma’s ZG005 Approved for Gastrointestinal Tumor Trials in China
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced that it has received approval from China’s...
HemaCell’s XJ-MK-002 Gains FDA Orphan Drug Designation for Giant Platelet Syndrome
China-based Suzhou Xueji Biotechnology Co., Ltd (HemaCell), a pioneer in platelet regeneration-focused cell therapy, announced...
IVIEW Therapeutics’ IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis
China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the...
Hansoh Pharma’s Ibrexafungerp Approved for Vulvovaginal Candidiasis in China
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) announced this week that it has received...
Hengrui Pharmaceuticals’ Ivarmacitinib Approved for Atopic Dermatitis
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received additional indication approval...
Beijing StarMab’s SM2275 Receives FDA IND Approval for Dual-Target Cancer Therapy
China-based Beijing StarMab BioMed Technology, Ltd. announced that it has received Investigational New Drug (IND)...
GE Healthcare Appoints Jeannette Bankes as President and CEO of Patient Care Solutions
GE Healthcare Technologies Inc. (NASDAQ: GEHC) announced this week the appointment of Jeannette Bankes as...